James Earl Radford Jr. MD
Hematologist in Hendersonville, North Carolina and is affiliated with
Join to view full profile
805 6th Ave WHendersonville, NC 28739
Phone+1 828-692-8045
Fax+1 828-692-6630
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Radford Jr., MD is an oncologist in Hendersonville, North Carolina. He is currently licensed to practice medicine in North Carolina, Minnesota, and Iowa. He is a Hematologist in Hendersonville at North Carolina and is affiliated with.
Education & Training
University of Iowa Health Care Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989- University of Iowa Health Care Medical CenterResidency, Internal Medicine, 1983 - 1986
University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
NC State Medical License 1994 - 2027
IA State Medical License 1983 - 1999- IA State Medical License 1983 - 1999
MN State Medical License 1991 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- 10 citationsEfficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemothe...Hakan Kaya, Yi-Kong Keung, Douglas Case, Julia M. Cruz, JJ Perry
Biology of Blood and Marrow Transplantation. 2002-10-01 - 74 citationsDetection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantationElisabetta Abruzzese, James E. Radford, Jeffrey S. Miller, James J. Vredenburgh, P. Nagesh Rao
Blood. 1999-09-01 - 84 citationsLow dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.Jeffrey S. Miller, Jennifer A. Tessmer-Tuck, Bryce A. Pierson, Daniel J. Weisdorf, Philip B. McGlave
Biology of Blood and Marrow Transplantation. 1997-04-01
Press Mentions
Dr. Radford Leaves Legacy of Lives Saved, Research to Fight CancerDecember 24th, 2021